Author rebuttal to response regarding “Letter to the Editor regarding ‘Could pulmonary arterial hypertension patients be at lower risk from severe COVID-19?’”
E. Horn,M. Chakinala,2 Authors,E. Rosenzweig
2020 · DOI: 10.1177/2045894020936663
Pulmonary Circulation · 5 Citations
TLDR
This work presents a novel, scalable, scalable and scalable approach that allows for real-time assessment of the individual risks and benefits of smoking cessation and its applications in patients with smoking-related illnesses.
Abstract
Evelyn Horn, Murali M. Chakinala, Ronald Oudiz, Elizabeth Joseloff and Erika B. Rosenzweig Weill Cornell Medicine, New York Presbyterian Hospital, New York, USA; School of Medicine, Washington University in Saint Louis, St. Louis, MO, USA; David Geffen School of Medicine at UCLA, UCLA Medical Center, Santa Monica, CA, USA; Pulmonary Hypertension Association Silver Spring, MD, USA; Departments of Pediatrics and Medicine, Columbia University Medical Center, New York, NY, USA
Cited Papers
Citing Papers